300 related articles for article (PubMed ID: 30739788)
1. Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide.
Imaruoka K; Oe Y; Fushima T; Sato E; Sekimoto A; Sato H; Sugawara J; Ito S; Takahashi N
Biochem Biophys Res Commun; 2019 Mar; 510(4):587-593. PubMed ID: 30739788
[TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice.
Huang X; Xie Z; Liu F; Han C; Zhang D; Wang D; Bao X; Sun J; Wen C; Fan Y
Int Immunopharmacol; 2014 Sep; 22(1):266-72. PubMed ID: 25027631
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
4. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
Zhai JX; Zhang ZX; Feng YJ; Ding SS; Wang XH; Zou LW; Ye DQ
Mol Biol Rep; 2012 Jun; 39(6):6763-71. PubMed ID: 22318546
[TBL] [Abstract][Full Text] [Related]
5. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
Cruse JM; Lewis RE; Dilioglou S
Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.
Knight JS; Subramanian V; O'Dell AA; Yalavarthi S; Zhao W; Smith CK; Hodgin JB; Thompson PR; Kaplan MJ
Ann Rheum Dis; 2015 Dec; 74(12):2199-206. PubMed ID: 25104775
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide ameliorates a preeclampsia-like condition in mice with reduced uterine perfusion pressure.
Fushima T; Sekimoto A; Oe Y; Sato E; Ito S; Sato H; Takahashi N
Am J Physiol Renal Physiol; 2017 Feb; 312(2):F366-F372. PubMed ID: 27927652
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.
Oaks Z; Winans T; Caza T; Fernandez D; Liu Y; Landas SK; Banki K; Perl A
Arthritis Rheumatol; 2016 Nov; 68(11):2728-2739. PubMed ID: 27332042
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
Hoi AY; Hickey MJ; Hall P; Yamana J; O'Sullivan KM; Santos LL; James WG; Kitching AR; Morand EF
J Immunol; 2006 Oct; 177(8):5687-96. PubMed ID: 17015758
[TBL] [Abstract][Full Text] [Related]
11. Treatment with lysophosphatidic acid improves glomerulonephritis through the suppression of macrophage activation in a murine model of systemic lupus erythematosus.
Nagata W; Takayama E; Nakagawa K; Koizumi A; Ohsawa Y; Goto H; Yamashiro A; Ishinoda Y; Tanoue K; Kumagai H; Oshima N; Ishizuka T
Clin Exp Rheumatol; 2024 Mar; 42(3):658-665. PubMed ID: 38436267
[TBL] [Abstract][Full Text] [Related]
12. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
[TBL] [Abstract][Full Text] [Related]
13. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway.
Chen XC; Wu D; Wu HL; Li HY; Yang C; Su HY; Liu ZJ; Huang XR; Lu X; Huang LF; Zhu SP; Pan QJ; An N; Liu HF
Lupus Sci Med; 2022 Apr; 9(1):. PubMed ID: 35414608
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
[TBL] [Abstract][Full Text] [Related]
15. CX
Cabana-Puig X; Lu R; Geng S; Michaelis JS; Oakes V; Armstrong C; Testerman JC; Liao X; Alajoleen R; Appiah M; Zhang Y; Reilly CM; Li L; Luo XM
Inflamm Res; 2023 May; 72(5):1083-1097. PubMed ID: 37060359
[TBL] [Abstract][Full Text] [Related]
16. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
[TBL] [Abstract][Full Text] [Related]
17. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
18. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist.
Itto R; Oe Y; Imaruoka K; Sato E; Sekimoto A; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N
Tohoku J Exp Med; 2019 Oct; 249(2):127-133. PubMed ID: 31666446
[TBL] [Abstract][Full Text] [Related]
19. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
20. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
Wei S; Yoshida N; Finn G; Kozono S; Nechama M; Kyttaris VC; Zhen Zhou X; Tsokos GC; Ping Lu K
Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
